IGM Biosciences IGMS, a clinical-stage company, is developing a pipeline of Immunoglobin M (IgM) antibody-based candidates to treat patients with cancer and autoimmune and inflammatory diseases. The ...
Is IGM Biosciences, Inc. (NASDAQ:IGMS) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback